Phase 1 Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with extensive-stage small cell lung cancer (a type of lung cancer that has spread), confirmed by a tissue or cell sample test
- You fully understand the study and are willing to sign a consent form agreeing to take part
- You are a man or woman between 18 and 75 years old
- You are fairly active and able to carry out daily activities with little or no limitation (confirmed by a standard health score of 0 or 1 — confirm with trial site)
- Your doctor expects you to live for at least 3 more months
Who may not be able to join:
- Your doctor or the trial team has decided, for any reason, that this trial is not a good fit for you (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jason Wu, Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phone: 17602176888
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of Participants Experiencing Dose-limiting toxicities (DLTs); Number of Participants Experiencing Treatment-emergent Adverse Events (TEAEs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.